Joao Paulo Falcao Malagueira Net Worth

The estimated Net Worth of Joao Paulo Falcao Malagueira is at least $323 Mille dollars as of 17 June 2024. Joao Malagueira owns over 1,749 units of Tandem Diabetes Care Inc stock worth over $323,167 and over the last 2 years Joao sold TNDM stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Joao Malagueira TNDM stock SEC Form 4 insiders trading

Joao has made over 3 trades of the Tandem Diabetes Care Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Joao exercised 1,749 units of TNDM stock worth $79,282 on 17 June 2024.

The largest trade Joao's ever made was exercising 4,065 units of Tandem Diabetes Care Inc stock on 22 May 2024 worth over $210,282. On average, Joao trades about 1,513 units every 74 days since 2022. As of 17 June 2024 Joao still owns at least 7,563 units of Tandem Diabetes Care Inc stock.

You can see the complete history of Joao Malagueira stock trades at the bottom of the page.

What's Joao Malagueira's mailing address?

Joao's mailing address filed with the SEC is 12400, High Bluff Drive, San Diego, San Diego County, California, 92130, United States.

Insiders trading at Tandem Diabetes Care Inc

Over the last 11 years, insiders at Tandem Diabetes Care Inc have traded over $154,253,951 worth of Tandem Diabetes Care Inc stock and bought 4,118,443 units worth $11,618,906 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Douglas A Roeder e Nicole Vitullo. On average, Tandem Diabetes Care Inc executives and independent directors trade stock every 9 days with the average trade being worth of $885,878. The most recent stock trade was executed by Shannon Marie Hansen on 15 August 2024, trading 1,968 units of TNDM stock currently worth $84,093.

What does Tandem Diabetes Care Inc do?

tandem diabetes care, inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. the company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. tandem manufactures and sells the t:slim x2™ insulin pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® insulin pump, the first pump designed for people with greater insulin requirements. tandem is based in san diego, california. safety information please note that this account is not intended to be used for product support or medical advice. if you are having a medical emergency, please dial 911. if you are having an issue with one of our products and need immediate assistance, please call our 24 hour customer support team at 877-801-6901 and press 1 twice. tandem insulin pumps are intended for the subcutan

Complete history of Joao Malagueira stock trades at Tandem Diabetes Care Inc

Tandem Diabetes Care Inc executives and stock owners

Tandem Diabetes Care Inc executives and other stock owners filed with the SEC include:

• John Sheridan,
  President, Chief Executive Officer, Director
• Kim Blickenstaff,
  Chairman of the Board
• Brian Hansen,
  Chief Commercial Officer, Executive Vice President
• Leigh Vosseller,
  Chief Financial Officer, Executive Vice President, Treasurer
• David Berger,
  Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary
• Susan Morrison,
  Executive Vice President, Chief Administrative Officer
• Rebecca Robertson,
  Independent Director
• John F. Sheridan,
  Pres, CEO & Director
• David B. Berger Esq.,
  Exec. VP & COO
• Elizabeth Anne Gasser,
  Exec. VP & Chief Strategy Officer
• Brian B. Hansen,
  Exec. VP & Chief Commercial Officer
• Leigh A. Vosseller,
  Exec. VP, CFO & Treasurer
• David B. Berger,
  Exec. VP, Chief Bus. Operations & Compliance Officer and Corp. Sec.
• Susan M. Morrison,
  Exec. VP & Chief Admin. Officer
• Dick Allen,
  Lead Independent Director
• Christopher Twomey,
  Independent Director
• Douglas Roeder,
  Independent Director
• Edward Cahill,
  Independent Director
• Peyton Howell,
  Independent Director
• Kathleen McGroddy-Goetz,
  Independent Director
• Elizabeth Gasser,
  Executive Vice President - Strategy and Corporate Development
• Shannon M. Hansen,
  Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec.
• Manuel Jaime,
  Sr. VP of Technology & Digital Health
• Tom Fox,
  Sr. VP of HR & Organizational Devel.
• Ross Sylvia,
  VP of Marketing
• Rick Carpenter,
  Chief Technical Officer
• Jim Leal,
  Sr. VP of Operations
• Richard P. Valencia,
  Director
• Jesse I Treu,
  Director
• Howard E Jr Greene,
  Director
• Fred E Cohen,
  Director
• Lonnie M Smith,
  Director
• Henry Anhalt,
  Director
• John Cajigas,
  CHIEF FINANCIAL OFFICER
• Management Partners Viii, L...,
  
• Venture Partners Ii, L.P.Hl...,
  
• Group Holdings (Sbs) Adviso...,
  
• Parters Vii L P Domain,
  10% owner
• Nicole Vitullo,
  10% owner
• Kathleen K Schoemaker,
  10% owner
• Brian K Halak,
  10% owner
• Robert Anacone,
  EXECUTIVE VP AND CCO
• Brian H Dovey,
  10% owner
• James C Blair,
  10% owner
• Vii Associates Lp Dp,
  10% owner
• Jean Claude Kyrillos,
  EVP & Chief Operating Officer
• Rajwant Sodhi,
  Director
• James Leal,
  Chief Manufacturing Officer
• Shannon Marie Hansen,
  EVP & Chief Legal Officer
• Myoungil Cha,
  Director
• Joao Paulo Falcao Malagueira,
  Director
• Mark David Novara,
  EVP & CHIEF COMMERCIAL OFFICER
• Rick Carpenter,
  Chief Technology Officer